No BS Just Facts logo
No BS Just Facts
It might be boring, but it's just the facts.

← All stories · business

CNBC

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Monday, November 16, 2026


Novo Nordisk's Wegovy injection met its primary endpoint in a trial testing the drug in children under 12 with obesity, lowering body mass index compared to placebo, the company announced. Wegovy is currently approved to treat obesity in children ages 12 and older. The company did not immediately release detailed efficacy or safety data from the trial.

Original reporting:

Next story

Landmark Crimea bridge hit as Russia reports biggest Ukrainian drone attack of war→